MetLife Investment Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Hold |
54,480
| – | – | ﹤0.01% | 2010 |
|
|
2025
Q1 | $353K | Sell |
54,480
-1,013
| -2% | -$6.56K | ﹤0.01% | 1899 |
|
|
2024
Q4 | $407K | Buy |
55,493
+4,758
| +9% | +$34.9K | ﹤0.01% | 1911 |
|
|
2024
Q3 | $380K | Hold |
50,735
| – | – | ﹤0.01% | 1935 |
|
|
2024
Q2 | $452K | Buy |
50,735
+6,578
| +15% | +$58.5K | ﹤0.01% | 1776 |
|
|
2024
Q1 | $447K | Hold |
44,157
| – | – | ﹤0.01% | 1737 |
|
|
2023
Q4 | $444K | Hold |
44,157
| – | – | ﹤0.01% | 1760 |
|
|
2023
Q3 | $414K | Hold |
44,157
| – | – | ﹤0.01% | 1749 |
|
|
2023
Q2 | $1.08M | Buy |
44,157
+6,400
| +17% | +$157K | 0.01% | 1225 |
|
|
2023
Q1 | $879K | Hold |
37,757
| – | – | 0.01% | 1284 |
|
|
2022
Q4 | $956K | Hold |
37,757
| – | – | 0.01% | 1236 |
|
|
2022
Q3 | $728K | Hold |
37,757
| – | – | 0.01% | 1373 |
|
|
2022
Q2 | $962K | Buy |
37,757
+4,581
| +14% | +$117K | 0.01% | 1226 |
|
|
2022
Q1 | $853K | Buy |
33,176
+11,534
| +53% | +$297K | 0.01% | 1435 |
|
|
2021
Q4 | $906K | Hold |
21,642
| – | – | 0.01% | 1170 |
|
|
2021
Q3 | $942K | Hold |
21,642
| – | – | 0.01% | 1142 |
|
|
2021
Q2 | $1.02M | Buy |
21,642
+1,270
| +6% | +$60K | 0.01% | 1149 |
|
|
2021
Q1 | $1.04M | Sell |
20,372
-2,484
| -11% | -$127K | 0.01% | 1134 |
|
|
2020
Q4 | $612K | Hold |
22,856
| – | – | 0.01% | 1376 |
|
|
2020
Q3 | $785K | Buy |
22,856
+2,273
| +11% | +$78K | 0.01% | 1150 |
|
|
2020
Q2 | $843K | Buy |
20,583
+17,201
| +509% | +$705K | 0.01% | 1097 |
|
|
2020
Q1 | $116K | Buy |
+3,382
| New | +$116K | ﹤0.01% | 1996 |
|